推进肿瘤病理研究报告:世界卫生组织肿瘤分类 EVI MAP 小组病理学家指南。

IF 7.1 1区 医学 Q1 PATHOLOGY Modern Pathology Pub Date : 2024-05-17 DOI:10.1016/j.modpat.2024.100515
Richard Colling , Iciar Indave , Javier Del Aguilla , Ramon Cierco Jimenez , Fiona Campbell , Magdalena Chechlinska , Magdalena Kowalewska , Stefan Holdenrieder , Inga Trulson , Karolina Worf , Marina Pollán , Elena Plans-Beriso , Beatriz Pérez-Gómez , Oana Craciun , Ester García-Ovejero , Irmina Maria Michalek , Kateryna Maslova , Grzegorz Rymkiewicz , Joanna Didkowska , Puay Hoon Tan , Ian A. Cree
{"title":"推进肿瘤病理研究报告:世界卫生组织肿瘤分类 EVI MAP 小组病理学家指南。","authors":"Richard Colling ,&nbsp;Iciar Indave ,&nbsp;Javier Del Aguilla ,&nbsp;Ramon Cierco Jimenez ,&nbsp;Fiona Campbell ,&nbsp;Magdalena Chechlinska ,&nbsp;Magdalena Kowalewska ,&nbsp;Stefan Holdenrieder ,&nbsp;Inga Trulson ,&nbsp;Karolina Worf ,&nbsp;Marina Pollán ,&nbsp;Elena Plans-Beriso ,&nbsp;Beatriz Pérez-Gómez ,&nbsp;Oana Craciun ,&nbsp;Ester García-Ovejero ,&nbsp;Irmina Maria Michalek ,&nbsp;Kateryna Maslova ,&nbsp;Grzegorz Rymkiewicz ,&nbsp;Joanna Didkowska ,&nbsp;Puay Hoon Tan ,&nbsp;Ian A. Cree","doi":"10.1016/j.modpat.2024.100515","DOIUrl":null,"url":null,"abstract":"<div><p>Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer’s International Collaboration for Cancer Classification and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-specific reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fit tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature.</p></div>","PeriodicalId":18706,"journal":{"name":"Modern Pathology","volume":null,"pages":null},"PeriodicalIF":7.1000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0893395224000954/pdfft?md5=9d39147cd941fd31d0a90056f6918b97&pid=1-s2.0-S0893395224000954-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group\",\"authors\":\"Richard Colling ,&nbsp;Iciar Indave ,&nbsp;Javier Del Aguilla ,&nbsp;Ramon Cierco Jimenez ,&nbsp;Fiona Campbell ,&nbsp;Magdalena Chechlinska ,&nbsp;Magdalena Kowalewska ,&nbsp;Stefan Holdenrieder ,&nbsp;Inga Trulson ,&nbsp;Karolina Worf ,&nbsp;Marina Pollán ,&nbsp;Elena Plans-Beriso ,&nbsp;Beatriz Pérez-Gómez ,&nbsp;Oana Craciun ,&nbsp;Ester García-Ovejero ,&nbsp;Irmina Maria Michalek ,&nbsp;Kateryna Maslova ,&nbsp;Grzegorz Rymkiewicz ,&nbsp;Joanna Didkowska ,&nbsp;Puay Hoon Tan ,&nbsp;Ian A. Cree\",\"doi\":\"10.1016/j.modpat.2024.100515\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer’s International Collaboration for Cancer Classification and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-specific reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fit tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature.</p></div>\",\"PeriodicalId\":18706,\"journal\":{\"name\":\"Modern Pathology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0893395224000954/pdfft?md5=9d39147cd941fd31d0a90056f6918b97&pid=1-s2.0-S0893395224000954-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0893395224000954\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0893395224000954","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

对于从事肿瘤病理研究的人员来说,循证医学(EBM)可能是一个陌生的领域,而且对于如何采用循证医学方法来规划和报告基于组织病理学的研究还存在很多不确定性。本文经世界卫生组织国际癌症研究机构的国际癌症分类与研究合作组织审查并认可,旨在帮助病理学家和研究人员了解循证肿瘤病理学研究规划的基本知识,以及我们对如何报告研究结果的建议。我们介绍了一些基本的 EBM 概念、研究问题框架、研究设计思路,并强调了报告标准的概念。目前有许多针对特定研究的报告指南,我们将对这些指南进行概述。然而,现有的报告指南可能并不总是适合肿瘤病理研究论文,因此,我们在此将关键的报告数据整理成一份通用的清单,我们认为这将简化病理学家的工作。本文旨在补充我们最近发布的肿瘤病理学证据等级和肿瘤病理学证据(研究)类型词汇表。这些文章合在一起,应能帮助任何研究人员掌握 EBM 的基础知识,以规划和发表肿瘤病理学研究,并鼓励提高文献报告的标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group

Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer’s International Collaboration for Cancer Classification and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-specific reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fit tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Modern Pathology
Modern Pathology 医学-病理学
CiteScore
14.30
自引率
2.70%
发文量
174
审稿时长
18 days
期刊介绍: Modern Pathology, an international journal under the ownership of The United States & Canadian Academy of Pathology (USCAP), serves as an authoritative platform for publishing top-tier clinical and translational research studies in pathology. Original manuscripts are the primary focus of Modern Pathology, complemented by impactful editorials, reviews, and practice guidelines covering all facets of precision diagnostics in human pathology. The journal's scope includes advancements in molecular diagnostics and genomic classifications of diseases, breakthroughs in immune-oncology, computational science, applied bioinformatics, and digital pathology.
期刊最新文献
Proximal and classic epithelioid sarcomas are distinct molecular entities defined by MYC/GATA3 and SOX17/endothelial markers, respectively. Refining Diagnostic Subtypes of Peripheral T-cell Lymphoma Using a Multiparameter Approach. Clinicopathologic characteristics and follow up outcomes of invasive breast carcinoma with different positive HER2 fluorescence in situ hybridization patterns: experience from a single academic institution. Evaluation of a task specific self-supervised learning framework in digital pathology relative to transfer learning approaches and existing foundation models. GLI1-altered Mesenchymal Tumor - Multi-omic Characterization of a Case Series and Patient-level Meta-analysis of 167 cases for Risk Stratification.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1